Skip to main content

Single Immediate Intravesical Instillation of Chemotherapy- Rationale and Practical Considerations

  • Chapter
  • First Online:
Bladder Cancer
  • 1031 Accesses

Abstract

As numerously depicted elsewhere in this book, the clinical problem of well-differentiated nonmuscle-invasive bladder cancer is the markedly high recurrence rate. A valuable tool of the management of these tumors is single immediate instillation, dubbed early instillation, i.e., a single dose of chemotherapy instilled into the bladder immediately after transurethral resection of bladder tumor (TURBT). In this chapter, the rationale and practical considerations of single immediate instillations directly after TURBT are lined out. Single immediate instillation is effective in nonmuscle-invasive bladder cancer of low-risk constellation, i.e., primary, solitary, and small tumors with presumed high-grade differentiation. As agents, mitomycin C, epirubicin, pirarubicin, and gemcitabine have been assessed with largely comparable effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Babjuk M, Burger M, Compérat E, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R. Guidelines Associates: Capoun O, Cohen D, Dominguez Escrig JL, Hernandez V, Peyronnet B, Seisen T, Soukup V. EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). EAU guidelines. Edn. presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2. EAU Guidelines Office, Arnhem, The Netherlands.

    Google Scholar 

  2. Böhle A, Leyh H, Frei C, Kühn M, Tschada R, Pottek T, Wagner W, Knispel HH, von Pokrzywnitzki W, Zorlu F, Helsberg K, Lübben B, Soldatenkova V, Stoffregen C, Büttner H, S274 Study Group. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur Urol. 2009;56(3):495–503.

    Article  Google Scholar 

  3. Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJA. Value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer: a prospective multicentre randomised study in 2243 patients. Eur Urol. 2018;73(2):226–32.

    Article  CAS  Google Scholar 

  4. Brocks CP, Büttner H, Böhle A. Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. J Urol. 2005;174(3):1115–8.

    Article  Google Scholar 

  5. Gudjónsson S, Adell L, Merdasa F, Olsson R, Larsson B, Davidsson T, Richthoff J, Hagberg G, Grabe M, Bendahl PO, Månsson W, Liedberg F. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study. Eur Urol. 2009;55(4):773–80.

    Article  Google Scholar 

  6. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K. Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle-invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin C. BMC Urol. 2018;18(1):93. https://doi.org/10.1186/s12894-018-0408-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Oddens JR, van der Meijden AP, Sylvester R. One immediate postoperative instillation of chemotherapy in low- risk Ta, T1 bladder cancer patients. Is it always safe? Eur Urol. 2004;46(3):336–8.

    Article  CAS  Google Scholar 

  8. Soloway MS, Masters S. Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer. 1980;46(5):1158–63.

    Article  CAS  Google Scholar 

  9. Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S, De Nunzio C, Okamura K, Kaasinen E, Solsona E, Ali-El-Dein B, Tatar CA, Inman BA, N’Dow J, Oddens JR, Babjuk M. Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol. 2016;69(2):231–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Max Burger .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burger, M. (2021). Single Immediate Intravesical Instillation of Chemotherapy- Rationale and Practical Considerations. In: Kamat, A.M., Black, P.C. (eds) Bladder Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-70646-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70646-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70645-6

  • Online ISBN: 978-3-030-70646-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics